CASI Pharmaceuticals (CASI) PT Lowered to $10 at BTIG
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts CASI Hot Sheet
Price: $0.21 --0%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 17 | New: 0
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 17 | New: 0
Join SI Premium – FREE
BTIG analyst Justin Zelin lowered the price target on CASI Pharmaceuticals (NASDAQ: CASI) to $10.00 (from $21.00) while maintaining a Buy rating.
You May Also Be Interested In
- Raymond James Downgrades First Busey (BUSE) to Market Perform
- Shell PLC (SHEL:LN) (SHEL) PT Raised to GBP41 at RBC Capital
- Suncorp Group Ltd. (SUN:AU) (SNMCY) PT Raised to AUD21.80 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
